Metrics
- Price
- $27.00
- Market Cap $M
- 1,438
- Rel Volume
- 1.22
- Vol Up 2W
- 66.7%
- Vol Trend 2W
- +364.3%
- 1D
- +0.0%
- 1W
- +0.2%
- 1M
- +1.0%
- 1M Slope
- +1.1%
- 6M Range
- 87.5%
- Score
- 74.4
- Sharp
- 1.1
Volume
Profile
KalVista Pharmaceuticals develops small-molecule drugs for hereditary angioedema and other inflammatory disorders, advancing clinical-stage treatments for rare diseases.
Biotech
Pharmaceuticals
Healthcare